Literature DB >> 2839961

Naloxone antagonizes a central histaminergic stimulation of corticosterone secretion in rats.

A Gadek-Michalska1, J Bugajski.   

Abstract

The interaction of central opioid receptors with histaminergic stimulation of the hypothalamo-pituitary-adrenocortical axis, evaluated indirectly through corticosterone secretion, was investigated in conscious unstressed rats. To avoid any possible direct action on the adrenal cortex, all drugs were given intracerebroventricularly (i.c.v.). Histamine, 2-pyridylethylamine (PEA), a histamine H1-receptor agonist, and 4-methyl-histamine (MeHA) and dimaprit, the H2-receptor agonists, considerably increased the serum corticosterone levels 1 h after administration. Naloxone, an opioid receptor antagonist, almost abolished the corticosterone response to PEA and considerably reduced the responses to MeHA, dimaprit and histamine. The maximum inhibitory effects of naloxone on corticosterone responses induced by histamine and histamine agonists were comparable with those of the H1- and H2-receptor antagonists, mepyramine and cimetidine. These results strongly suggest that a major part of the histaminergic stimulation of the hypothalamo-pituitary-adrenal axis is mediated by central opioid receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839961     DOI: 10.1007/BF02142556

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  8 in total

1.  Involvement of central histamine receptors in corticosterone secretion induced by intraventricular administration of morphine.

Authors:  B Cetera; J Bugajski; A Gadek-Michalska
Journal:  Agents Actions       Date:  1988-04

2.  Naloxone has a direct effect on the adrenal cortex.

Authors:  J R Lymangrover; L A Dokas; A Kong; R Martin; M Saffran
Journal:  Endocrinology       Date:  1981-10       Impact factor: 4.736

3.  Effect of intraventricular histamine on hormone secretion in dogs.

Authors:  C Rudolph; G E Richards; S Kaplan; W F Ganong
Journal:  Neuroendocrinology       Date:  1979       Impact factor: 4.914

Review 4.  Endocrine actions of opioids.

Authors:  A Pfeiffer; A Herz
Journal:  Horm Metab Res       Date:  1984-08       Impact factor: 2.936

5.  Central histaminergic stimulation of pituitary--adrenocortical response in the rat.

Authors:  J Bugajski; Z Janusz
Journal:  Life Sci       Date:  1983-09-19       Impact factor: 5.037

6.  Cholinergic and histaminergic involvement in the growth hormone releasing effect of an enkephalin analog FK 33-824 in man.

Authors:  A Peñalva; L Villanueva; F Casanueva; F Cavagnini; A Gomez-Pan; E E Müller
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

7.  Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.

Authors:  F Yajima; T Suda; N Tomori; T Sumitomo; Y Nakagami; T Ushiyama; H Demura; K Shizume
Journal:  Life Sci       Date:  1986-07-14       Impact factor: 5.037

8.  Influence of naloxone on H2-receptor blocker drugs effects in the "behavioral despair" test.

Authors:  R Sunal
Journal:  Pharmacol Biochem Behav       Date:  1986-09       Impact factor: 3.533

  8 in total
  3 in total

1.  Dimaprit--induced neurotoxicity.

Authors:  R L Swaab; A M Battles; C A Bruner; L B Hough
Journal:  Agents Actions       Date:  1992-03

2.  Antagonistic action of naloxone on central histamine receptors-stimulated corticosterone secretion in rats under stress.

Authors:  A Gadek-Michalska; J Bugajski
Journal:  Agents Actions       Date:  1989-11

3.  Antagonistic effect of naloxone on the hypertensive response of intraventricularly administered histamine.

Authors:  M S Młynarska
Journal:  Agents Actions       Date:  1990-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.